The fund’s strategy, top holdings, and recent portfolio moves are explored to provide insights for existing and potential ...

The fund’s strategy, top holdings, and recent portfolio moves are explored to provide insights for existing and potential ...

Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing.

Pharma Sector Multibagger Opportunity - Explore how India could win big in the CDMO space with China-Plus-One strategy, ...

For benchmark Nifty-50 index, 23650 will be the key level to watch. Below this level, the market could continue its weak ...

Welcome to the ITC Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ...

For many economists, India now is in what they call a “cyclical growth slowdown”: essentially a slump in demand that causes a ...

MakeMyTrip appears in over 70% of Google's organic search results for hotels in India, leading the market.

We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not ...

Choice Broking executive director Sumeet Bagadia suggested purchasing two stocks after the Nifty on the daily chart formed a ...

Choice Brokings executive director, Sumeet Bagadia, recommended buying two stocks on Tuesday, January 14 when the Nifty broke ...

Sun Pharmaceuticals has emerged as a key speciality player, with global speciality revenues rising from 7% in FY18 to 18% in ...